Battelle to Develop Epigenome Identifier Tech Under DARPA Agreement

Jeff Brody

Battelle has entered into a contractor agreement with the Defense Advanced Research Projects Agency to develop a platform designed to identify epigenome signatures that could be used to determine an individual’s exposure to materials associated with weapons of mass destruction.

Under DARPA’s Epigenetic Characterization and Observation program, Battelle said Monday it will identify unique signatures by comparing blood samples from individuals that have dealt with chemical, biological, pesticide or herbicide contaminants to those of control subjects.

“We’ll be developing methods to identify these signatures and how to interpret them for attribution—what did the person handle, when and for how long,” said Rachel Spurbeck, a principal research scientist and biologist at Battelle. “This will even allow for diagnosing illnesses in individuals as a result of their exposure.”

The nonprofit company said the proposed technology will trace a specific epigenome from a biological sample despite the absence of other physical evidence.

You may also be interested in...

a.i. solutions

a.i. solutions Wins Potential $203M MDA Advisory, Assistance Contract

Lanham, Maryland-based a.i. solutions has won a potential five-year, $203.2M contract to advise and assist the Missile Defense Agency on quality and mission assurance matters.

Hawk Carlisle President and CEO NDIA

NDIA Adds 16 Industry Execs to Board; Hawk Carlisle Quoted

Sixteen executives from the private sector have been appointed to serve on the National Defense Industrial Association’s board of directors for a term of up to six years. Herbert “Hawk” Carlisle, president and CEO of NDIA, said in a statement released Monday the new board members bring a “deep knowledge bank” he believes will help the organization sustain its mission while supporting the defense industrial base.